Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Furosemide versus furosemide + albumin for edema in stable chronic kidney disease
ACTRN12611000480987Phase 4Completed
- Sponsor
- Ramathibodi Foundation
- Start
- Jul 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of furosemide and albumin (human) in edema (2 arms), sponsored by Ramathibodi Foundation. Primary endpoints: Volume of urine output and Urine sodium. Started Jul 2010; status: completed.
02
Drugs
furosemidealbumin (human)
03
Conditions
edema
Beyond the preview
Go deeper on ACTRN12611000480987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000480987.